相关实验视频
Updated: Jan 16, 2026

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
Published on: September 26, 2013
在RA和其他自身免疫性关节炎疾病中,人体组织中的功能和功能障碍T调节细胞状态
Byunghee Koh1, Shani T Gal Oz1,2,3, Ryota Sato1,4
1Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
类风湿性关节炎 (RA) 突组织中的调节性T细胞 (Tregs) 显示出不同的功能和功能障碍状态. TNFR2的参与提供了一个潜在的治疗策略,以逆转Treg功能障碍在炎症性关节炎症.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 类风湿病学 类风湿病学
背景情况:
- 调节性T细胞 (Tregs) 对免疫平衡至关重要,但在类风湿性关节炎 (RA) 等自身免疫性疾病中受损.
- 以前对人类Tregs的研究主要集中在血液样本上,并没有研究突组织Treg群体.
研究的目的:
- 使用单细胞RNA测序,在RA患者的突组织内表征Treg子集.
- 阐明RA突关节膜中Treg功能障碍背后的机制,并确定潜在的治疗点.
主要方法:
- 单细胞RNA测序 (scRNAseq) 的Tregs从RA患者的突组织.
- 计算分析和体外实验以调查Treg功能和相互作用.
- 在青少年异常性关节炎 (JIA) 突组织中分析Treg子集.
主要成果:
- 确定了两个Treg状态:CD25hiCXCR6pos (抑制性) 和CD25loAREGpos (功能障碍,突特异性).
- 皮质醇诱导了AREG表达,损害了CD25loAREGpos Treg功能,并促进了结膜纤维细胞炎症.
- TNFR2的参与逆转了Treg功能障碍,而来自巨细胞的TNFα增强了CD25hiCXCR6pos Treg功能.
- 在JIA突组织中观察到类似的Treg子集,这表明保留了机制.
结论:
- 在炎症的突组织中存在不同的Treg状态,由特定的分子通路驱动.
- 在RA中功能障碍的Tregs的特征是AREG表达和抑制能力受损.
- 在炎症性关节炎中,TNFR2的参与为恢复Treg功能提供了一个有希望的治疗途径.
更多相关视频
10:10Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Published on: November 8, 2016
07:39Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper cTfh Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry
Published on: January 7, 2019
相关概念视频
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
The JAK-STAT Signaling Pathway
Cell-mediated Immune Responses